These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 7130339

  • 1. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
    Molitch ME, Goodman RH, Post KD, Biller BJ, Moses AC, King LW, Feldman ZT, Reichlin S.
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
    [Abstract] [Full Text] [Related]

  • 2. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA, Frohman LA.
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [Abstract] [Full Text] [Related]

  • 3. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
    Genazzani AR, De Leo V, Murru S, Cocchi D, Camanni F, Müller EE.
    J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
    [No Abstract] [Full Text] [Related]

  • 4. Carbidopa inhibits the growth hormone- and prolactin-suppressive effect of L-dopa in acromegalic patients.
    Camanni F, Picotti GB, Massara F, Molinatti GM, Mantegazza P, Müller EE.
    J Clin Endocrinol Metab; 1978 Sep; 47(3):647-52. PubMed ID: 263317
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic mechanisms regulating prolactin secretion in patients with prolactin-secreting pituitary adenoma. Long-term studies after selective transsphenoidal surgery.
    Barbarino A, De Marinis L, Anile C, Menini E, Merlini G, Maira G.
    Metabolism; 1982 Nov; 31(11):1100-4. PubMed ID: 6813636
    [Abstract] [Full Text] [Related]

  • 6. [Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
    De Leo V, Franchi F, Danero S, Ricci MG, La Marca S, Urbani TM, Pieroni ML, D'Antona N, Genazzani AR.
    Boll Soc Ital Biol Sper; 1983 Dec 30; 59(12):1883-9. PubMed ID: 6671047
    [Abstract] [Full Text] [Related]

  • 7. Effects of CNS dopamine augmentation on stimulated prolactin secretion.
    Woolf PD, Leebaw WJ, Lee LA.
    J Clin Endocrinol Metab; 1977 Oct 30; 45(4):857-60. PubMed ID: 410827
    [Abstract] [Full Text] [Related]

  • 8. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov 30; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 9. Functional characterization of hypothalamic hyperprolactinemia.
    Ferrari C, Rampini P, Benco R, Caldara R, Scarduelli C, Crosignani PG.
    J Clin Endocrinol Metab; 1982 Nov 30; 55(5):897-901. PubMed ID: 6811605
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
    Moriondo P, Travaglini P, Nissim M, Faglia G.
    Clin Endocrinol (Oxf); 1980 Dec 30; 13(6):525-33. PubMed ID: 7226570
    [Abstract] [Full Text] [Related]

  • 11. Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
    Rao R, Scommegna A, Frohman LA.
    Am J Obstet Gynecol; 1982 Aug 15; 143(8):883-7. PubMed ID: 7102764
    [Abstract] [Full Text] [Related]

  • 12. Carbidopa plus L-dopa pretreatment inhibits the prolactin (PRL) response to thyrotropin-releasing hormone and thus cannot distinguish central from pituitary sites of prolactin stimulation.
    Carlson HE.
    J Clin Endocrinol Metab; 1986 Jul 15; 63(1):249-51. PubMed ID: 3086358
    [Abstract] [Full Text] [Related]

  • 13. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
    Schlechte JA, Sherman BM, Chapler FK, VanGilder J.
    J Clin Endocrinol Metab; 1986 Jun 15; 62(6):1296-301. PubMed ID: 3084539
    [Abstract] [Full Text] [Related]

  • 14. Effects of hypothalamic dopamine (DA) on salsolinol (SAL)-induced prolactin (PRL) secretion in male goats.
    Jin J, Hara S, Sawai K, Fülöp F, Nagy GM, Hashizume T.
    Anim Sci J; 2014 Apr 15; 85(4):461-7. PubMed ID: 24329779
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease.
    Bell RD, Carruth A, Rosenberg RN, Boyar RM.
    J Clin Endocrinol Metab; 1978 Oct 15; 47(4):807-11. PubMed ID: 45469
    [Abstract] [Full Text] [Related]

  • 19. A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
    Ogawa A, Kanazawa M, Takayanagi M, Kitani Y, Shintaku H, Kohno Y.
    Brain Dev; 2008 Jan 15; 30(1):82-5. PubMed ID: 17590551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.